The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
A Phase 1, double blind, placebo controlled, single and multiple ascending dose, safety,
tolerability, pharmacokinetic, and pharmacodynamic study of HEC88473 in healthy subjects